XML 44 R37.htm IDEA: XBRL DOCUMENT v3.25.3
Business, Basis of Presentation and Significant Accounting Policies - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2023
Nature Of Operations [Line Items]          
Income tax expense $ 4,717 $ 94 $ 8,203 $ 674  
Net Income (Loss) $ 10,217 $ (820) $ 30,011 $ (27,221)  
Restatement [Member]          
Nature Of Operations [Line Items]          
Income tax expense         $ 3,000
Net Income (Loss)         $ (3,000)
Rose LifeScience Inc. [Member]          
Nature Of Operations [Line Items]          
Equity ownership percentage 80.00%   80.00%